In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Selpercatinib is a National Comprehensive Cancer Network (NCCN) recommended trea···【more】
Release date:2026-02-12Recommended:52
If you experience side effects, your doctor may adjust your dose, temporarily st···【more】
Release date:2026-02-12Recommended:33
Osimertinib is used to treat lung cancer. It works by blocking a protein that he···【more】
Release date:2026-02-11Recommended:56
Tell your healthcare provider about all the medicines you take, including prescr···【more】
Release date:2026-02-11Recommended:35
Medicines are sometimes used for purposes other than those listed in the patient···【more】
Release date:2026-02-11Recommended:46
Osimertinib is used for the prevention of recurrence in patients with non-small ···【more】
Release date:2026-02-11Recommended:37
Selumetinib is an oral small‑molecule kinase inhibitor.How to Take SelumetinibSw···【more】
Release date:2026-02-10Recommended:64
Before taking selumetinib, tell your doctor about all your medical conditions, i···【more】
Release date:2026-02-10Recommended:48
Selumetinib is used to treat type 1 neurofibromatosis (NF1) in pediatric patient···【more】
Release date:2026-02-10Recommended:37
Selumetinib is used to treat patients with neurofibromatosis type 1 (NF1) with p···【more】
Release date:2026-02-10Recommended:33
The dosage of this medicine is individualized. Please follow the doctor’s instru···【more】
Release date:2026-02-09Recommended:82
Sparsentan is indicated for slowing the progression of renal function decline in···【more】
Release date:2026-02-09Recommended:51